Company Profile

Arrowhead Pharmaceuticals Stock Price, News & Analysis

United StatesBiotechnologyNASDAQ

Company overview

Business overview

Arrowhead Pharmaceuticals is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Arrowhead Pharmaceuticals is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.

Business Model Characteristics

Arrowhead Pharmaceuticals follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.

Position Within the Biotechnology Landscape

Compared with more mature healthcare names, Arrowhead Pharmaceuticals sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.

Why the stock is moving

ARWR is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Future catalysts

Arrowhead's catalysts are plozasiran and the rest of its RNAi cardiometabolic franchise, especially the triglyceride and severe-hypertriglyceridemia path. The company needs each update to show that the platform can keep moving from a broad RNAi story into an actual commercial pipeline.

Recent news

The five most recent feed items are shown below in reverse chronological order.

  1. 01

    Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results

    Source: Arrowhead Pharmaceuticals

  2. 02

    Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results

    Source: Arrowhead Pharmaceuticals

  3. 03
  4. 04

    Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

    Source: Arrowhead Pharmaceuticals

  5. 05

    Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events

    Source: Arrowhead Pharmaceuticals

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.